Evenity 105 mg/1.17 ml
As listed in the register: Evenity 105 mg/1.17 ml, solution injectable en stylo prérempli
105 mg/1.17 ml ·
- Prescription only
- Muscles, joints and bones
- Active substance
- Romosozumabum
- Used in
- Muscles, joints and bones
- Made by
- UCB-Pharma SA
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Traitement de l'ostéoporose grave chez les femmes après la ménopause
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | UCB-Pharma SA |
|---|---|
| Active substance | Romosozumabum |
| Used in | Muscles, joints and bones |
| Strength | 105 mg/1.17 ml |
| Classification | M05BX06 · Muscles, joints and bones |
| Dispensing (as stated by the register) | Abgabekategorie B |
| Name in the register | Evenity 105 mg/1.17 ml, solution injectable en stylo prérempli |
| Packs | 2 Injektor(en), vorgefüllt/Pen |
| Zulassungsnummer | 67033 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.